vs
威伯科（CVGI）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是威伯科的1.3倍（$197.9M vs $154.8M），REPLIGEN CORP同比增速更快（13.6% vs -5.2%），REPLIGEN CORP自由现金流更多（$17.6M vs $8.7M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -10.8%）
威伯科控股曾是总部位于美国的重型商用车零部件供应商，主打电子制动、稳定性控制、悬挂及传动自动化系统，产品广泛应用于卡车、巴士、挂车以及非道路作业车辆等各类商用车领域，是商用车行业重要的零部件提供商。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CVGI vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.3倍
$154.8M
营收增速更快
RGEN
高出18.9%
-5.2%
自由现金流更多
RGEN
多$8.8M
$8.7M
两年增速更快
RGEN
近两年复合增速
-10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $154.8M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 9.7% | 52.5% |
| 营业利润率 | -1.2% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | -5.2% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVGIRGEN
| Q4 25 | $154.8M | $197.9M | ||
| Q3 25 | $152.5M | $188.8M | ||
| Q2 25 | $172.0M | $182.4M | ||
| Q1 25 | $169.8M | $169.2M | ||
| Q4 24 | $163.3M | $174.1M | ||
| Q3 24 | $171.8M | $154.9M | ||
| Q2 24 | $193.7M | $154.1M | ||
| Q1 24 | $194.6M | $151.3M |
净利润CVGIRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-7.1M | $14.9M | ||
| Q2 25 | $-4.8M | $14.9M | ||
| Q1 25 | $-4.3M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $9.5M | $-654.0K | ||
| Q2 24 | $-1.6M | $3.3M | ||
| Q1 24 | $2.9M | $2.1M |
毛利率CVGIRGEN
| Q4 25 | 9.7% | 52.5% | ||
| Q3 25 | 10.5% | 53.2% | ||
| Q2 25 | 11.4% | 50.0% | ||
| Q1 25 | 10.5% | 53.6% | ||
| Q4 24 | 8.0% | 26.1% | ||
| Q3 24 | 9.6% | 50.0% | ||
| Q2 24 | 10.6% | 49.8% | ||
| Q1 24 | 11.9% | 49.5% |
营业利润率CVGIRGEN
| Q4 25 | -1.2% | 9.0% | ||
| Q3 25 | -0.7% | 8.9% | ||
| Q2 25 | 0.5% | 7.6% | ||
| Q1 25 | 0.8% | 3.9% | ||
| Q4 24 | -3.2% | -17.7% | ||
| Q3 24 | -0.6% | -5.1% | ||
| Q2 24 | 0.5% | 1.0% | ||
| Q1 24 | 2.3% | 1.3% |
净利率CVGIRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -4.6% | 7.9% | ||
| Q2 25 | -2.8% | 8.2% | ||
| Q1 25 | -2.5% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 5.5% | -0.4% | ||
| Q2 24 | -0.8% | 2.2% | ||
| Q1 24 | 1.5% | 1.4% |
每股收益（稀释后）CVGIRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | $-0.05 | $0.06 | ||
| Q1 24 | $0.09 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | $104.9M | $542.2M |
| 股东权益账面价值 | $133.4M | $2.1B |
| 总资产 | $391.7M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.79× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CVGIRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务CVGIRGEN
| Q4 25 | $104.9M | $542.2M | ||
| Q3 25 | $108.2M | $537.9M | ||
| Q2 25 | $118.2M | — | ||
| Q1 25 | $117.4M | — | ||
| Q4 24 | $135.5M | $525.6M | ||
| Q3 24 | $128.8M | — | ||
| Q2 24 | $142.0M | — | ||
| Q1 24 | $155.7M | — |
股东权益CVGIRGEN
| Q4 25 | $133.4M | $2.1B | ||
| Q3 25 | $136.5M | $2.1B | ||
| Q2 25 | $142.6M | $2.1B | ||
| Q1 25 | $136.7M | $2.0B | ||
| Q4 24 | $135.6M | $2.0B | ||
| Q3 24 | $179.3M | $2.0B | ||
| Q2 24 | $169.6M | $2.0B | ||
| Q1 24 | $175.5M | $2.0B |
总资产CVGIRGEN
| Q4 25 | $391.7M | $2.9B | ||
| Q3 25 | $400.3M | $2.9B | ||
| Q2 25 | $429.8M | $2.9B | ||
| Q1 25 | $419.8M | $2.9B | ||
| Q4 24 | $424.6M | $2.8B | ||
| Q3 24 | $495.3M | $2.8B | ||
| Q2 24 | $503.2M | $2.9B | ||
| Q1 24 | $509.2M | $2.8B |
负债/权益比CVGIRGEN
| Q4 25 | 0.79× | 0.26× | ||
| Q3 25 | 0.79× | 0.26× | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 1.00× | 0.27× | ||
| Q3 24 | 0.72× | — | ||
| Q2 24 | 0.84× | — | ||
| Q1 24 | 0.89× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $8.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 5.6% | 8.9% |
| 资本支出强度资本支出/营收 | 2.3% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $34.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CVGIRGEN
| Q4 25 | $12.3M | $25.7M | ||
| Q3 25 | $-1.7M | $48.1M | ||
| Q2 25 | $18.9M | $28.6M | ||
| Q1 25 | $15.2M | $15.0M | ||
| Q4 24 | $-26.6M | $39.2M | ||
| Q3 24 | $-17.1M | $49.3M | ||
| Q2 24 | $12.6M | $42.2M | ||
| Q1 24 | $-2.4M | $44.7M |
自由现金流CVGIRGEN
| Q4 25 | $8.7M | $17.6M | ||
| Q3 25 | $-3.5M | $43.4M | ||
| Q2 25 | $17.4M | $21.5M | ||
| Q1 25 | $11.4M | $11.4M | ||
| Q4 24 | $-30.6M | $33.6M | ||
| Q3 24 | $-20.3M | $42.3M | ||
| Q2 24 | $6.4M | $37.4M | ||
| Q1 24 | $-7.4M | $36.4M |
自由现金流率CVGIRGEN
| Q4 25 | 5.6% | 8.9% | ||
| Q3 25 | -2.3% | 23.0% | ||
| Q2 25 | 10.1% | 11.8% | ||
| Q1 25 | 6.7% | 6.8% | ||
| Q4 24 | -18.7% | 19.3% | ||
| Q3 24 | -11.8% | 27.3% | ||
| Q2 24 | 3.3% | 24.3% | ||
| Q1 24 | -3.8% | 24.0% |
资本支出强度CVGIRGEN
| Q4 25 | 2.3% | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 0.9% | 3.9% | ||
| Q1 25 | 2.2% | 2.1% | ||
| Q4 24 | 2.4% | 3.2% | ||
| Q3 24 | 1.9% | 4.5% | ||
| Q2 24 | 3.2% | 3.1% | ||
| Q1 24 | 2.6% | 5.5% |
现金转化率CVGIRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.79× | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | -0.80× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVGI
| Global Seating | $70.7M | 46% |
| Global Electrical Systems | $49.7M | 32% |
| Trim Systems And Components | $34.4M | 22% |
RGEN
暂无分部数据
